HPCAL1 and cholangiocarcinoma: (A) IHC staining for HPCAL1 (B) Multivariate Cox analysis of clinicopathological variables and OS/RFS (C) Overall survival and relapse‐free survival in CCA patients with different levels of HPCAL1.